Skip to content

Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313

Retro- and Prospective Monocentric Study to Evaluate the Rate of Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS (Micro Incision Cataract Surgery) -IOL (Intraocular Lens) L313

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03184428
Enrollment
3785
Registered
2017-06-12
Start date
2015-10-01
Completion date
2018-12-10
Last updated
2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Capsule Opacification

Keywords

YAG-Laser Capsulotomy

Brief summary

This study collects intra- and postoperative data from the patients´charts retrospectively and evaluates retro- and prospectively the rate of posterior capsule opacification (PCO) following implantation of the intraocular lens L 313.

Detailed description

This study is a postmarket study without interventions. Within the Standard Care Cataract surgery the participants have been implanted with the intraocular lens L313 in the period between September 2009 and December 2013. As criterium for the PCO was considered the Nd:YAG capsulotomy. In the first step of the study, data was collected from the patients´charts. In the second phase, a questionaire was sent to the patients with no recent examination, asking them to answer whether or not participants received a laser procedure due to PCO. In doubt the participants could answer: I am not certain. For this step the investigator ensured the positive Votum of the Ethic Committee of the University of Greifswald, Germany. On the third step of the study, the patients that were not certain of having such a laser procedure or did not answer per post, will be contacted on telephone. By uncertainty or no answer on the telephone the family eye doctor will be contacted to receive the necessary information. If the eye doctor has lost contact to the patient, then this patient will be documented as lost-to-follow-up. Excluded were the patients that live \>50km from the Department of Ophthalmology in Neubrandenburg, as well as patients with intraoperative capsule tear. For the statistical analysis was used the program STATISTICA (StatSoft, Hamburg, Germany) and the survival analysis using the Kaplan-Meier formula, the statistical significance using the Chi-squared test and Spearman-Rank corelation and the Bonferroni adjustment if the test was repeated. The investigators compared these results with the results of other publication. In order to do that the investigators calculated the capsulotomy quote from this study according to the time of the PCO recorded on the other studies. Included were only comparing studies that also used YAG-capsulotomy as criterium for the PCO. Furthermore secondary data was collected: age, gender, cutting length, core hardness, duration of whole operation, time of phaco-emulsification, phaco-energy, phaco-machine, combination with other operation, surgeon, power of IOL. This data will be taken in concern for the validity of this study.

Interventions

OTHERPostoperative observation and survey

For postoperative Observation with a survey we ask the patients (or in case of no information the ophthalmologist) whether they had undergone a YAG-Laser-Capsulotomy after Cataract-Surgery or not.

Sponsors

Dietrich-Bonhoeffer-Klinikum
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* retrospective: Patients who have undergone a Cataract surgery with Implantation of IOL L313 * prospective: signed informed consent

Exclusion criteria

* capsule rupture * patients with too much travel distance between study center and home

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Yearsup to 8 yearsIn order to find out whether patients with cataract surgery are affected by lens opacification, we assessed whether a Nd:YAG laser capsulotomy was performed for treatment. For this purpose, the patient files were spotted first. Those who had no recent findings were asked in writing if and when a laser treatment was performed. In the absence of feedback and in case of uncertain or unusable written answer, a telephone consultation with the patient was made. If sufficient information was not available afterwards, the ophthalmologist was asked for information (by phone, by written request or by collecting the data on site in the practices).

Secondary

MeasureTime frameDescription
Correlation Coefficient Between Capsulotomy Rate and Parametersup to 8 yearsCorrelation coefficients between capsulotomy rate and patient parameters: 1. age 2. gender, and surgical parameters: 3. cutting length, 4. core hardness, 5. duration of whole operation, 6. time of phaco-emulsification, 7. phaco-energy, 8. phaco-machine, 9. combination with other operation, 10. surgeon, 11. power of IOL.

Countries

Germany

Participant flow

Recruitment details

Eyes of patients who underwent a cataract surgery in the Department of Ophthalmology in Neubrandenburg between September 2009 and December 2013 and had an L313 MICS lens implanted.

Pre-assignment details

The following reasons led to an exclusion of participants: * intraoperative posterior capsule rupture * Distance between place of residence and place of investigation \>50 km * Exchange of the intraocular lens * Practice closure of the supervising ophthalmologist * no entry in any established doctor's medical system * no follow-up

Participants by arm

ArmCount
Implantation of IOL L313
Patients who have undergone a cataract surgery with implantation of the monofocal MICS IOL L313 more than 3 Years ago will be asked about the treatment for postoperative observation and survey. Postoperative observation and survey: For postoperative observation with a survey we ask the patients (or in case of no information the ophthalmologist) whether they had undergone a Nd: YAG-Laser-Capsulotomy after Cataract-Surgery or not.
3,785
Implantation of IOL L313
Patients who have undergone a cataract surgery with implantation of the monofocal MICS IOL L313 more than 3 Years ago will be asked about the treatment for postoperative observation and survey. Postoperative observation and survey: For postoperative observation with a survey we ask the patients (or in case of no information the ophthalmologist) whether they had undergone a Nd: YAG-Laser-Capsulotomy after Cataract-Surgery or not.
5,549
Total9,334

Baseline characteristics

CharacteristicImplantation of IOL L313
Age, Categorical
<=18 years
2 eyes
Age, Categorical
>=65 years
4661 eyes
Age, Categorical
Between 18 and 65 years
886 eyes
Age, Continuous73.75 years
STANDARD_DEVIATION 9.06
Sex: Female, Male
Female
3285 eyes
Sex: Female, Male
Male
2264 eyes

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years

In order to find out whether patients with cataract surgery are affected by lens opacification, we assessed whether a Nd:YAG laser capsulotomy was performed for treatment. For this purpose, the patient files were spotted first. Those who had no recent findings were asked in writing if and when a laser treatment was performed. In the absence of feedback and in case of uncertain or unusable written answer, a telephone consultation with the patient was made. If sufficient information was not available afterwards, the ophthalmologist was asked for information (by phone, by written request or by collecting the data on site in the practices).

Time frame: up to 8 years

ArmMeasureGroupValue (NUMBER)
Implantation of IOL L313 Age<55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Yearsafter 6 years25.6 percentage of eyes
Implantation of IOL L313 Age<55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years1 year7.9 percentage of eyes
Implantation of IOL L313 Age<55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years2 years17.1 percentage of eyes
Implantation of IOL L313 Age<55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Yearsafter 4 years25.0 percentage of eyes
Implantation of IOL L313 Age≥55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Yearsafter 4 years17.2 percentage of eyes
Implantation of IOL L313 Age≥55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Yearsafter 6 years22.4 percentage of eyes
Implantation of IOL L313 Age≥55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years2 years8.2 percentage of eyes
Implantation of IOL L313 Age≥55Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years1 year4.7 percentage of eyes
Secondary

Correlation Coefficient Between Capsulotomy Rate and Parameters

Correlation coefficients between capsulotomy rate and patient parameters: 1. age 2. gender, and surgical parameters: 3. cutting length, 4. core hardness, 5. duration of whole operation, 6. time of phaco-emulsification, 7. phaco-energy, 8. phaco-machine, 9. combination with other operation, 10. surgeon, 11. power of IOL.

Time frame: up to 8 years

ArmMeasureValue (NUMBER)
Implantation of IOL L313 Age<55Correlation Coefficient Between Capsulotomy Rate and Parameters0.0001 Correlation coefficient
Implantation of IOL L313 Age≥55Correlation Coefficient Between Capsulotomy Rate and Parameters0.276 Correlation coefficient
Capsulotomy Rate/Cutting LenthCorrelation Coefficient Between Capsulotomy Rate and Parameters0.578 Correlation coefficient
Capsulotomy Rate/Core HardnessCorrelation Coefficient Between Capsulotomy Rate and Parameters0.041 Correlation coefficient
Capsulotomy Rate/Duration of Whole OperationCorrelation Coefficient Between Capsulotomy Rate and Parameters0.467 Correlation coefficient
Capsulotomy Rate/Time of Phaco-emulsificationCorrelation Coefficient Between Capsulotomy Rate and Parameters0.739 Correlation coefficient
Capsulotomy Rate/Phaco-energyCorrelation Coefficient Between Capsulotomy Rate and Parameters0.782 Correlation coefficient
Capsulotomy Rate/Phaco-machineCorrelation Coefficient Between Capsulotomy Rate and Parameters0.746 Correlation coefficient
Capsulotomy Rate/Combination With Other opCorrelation Coefficient Between Capsulotomy Rate and Parameters0.002 Correlation coefficient
Capsulotomy Rate/SurgeonCorrelation Coefficient Between Capsulotomy Rate and Parameters0.727 Correlation coefficient
Correlation Rate/Power of IOLCorrelation Coefficient Between Capsulotomy Rate and Parameters0.578 Correlation coefficient
p-value: <0.05Spearman's rank-order correlation

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026